Selected research
Industry Growth & Trends
Global Inactivated Probiotics Industry Growth and Trends Forecast to 2032
Market perspective
The global Inactivated Probiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Inactivated Probiotics include IFF, Huanyi, Scitop, GenMont Biotech, Harbin Qiutianhong Health Technology Group, Probioway, Lesaffre, Lallemand Health Solutions and Glac Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Inactivated Probiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Inactivated Probiotics market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inactivated Probiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inactivated Probiotics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Inactivated Probiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Inactivated Probiotics Market by Company
IFF
Huanyi
Scitop
GenMont Biotech
Harbin Qiutianhong Health Technology Group
Probioway
Lesaffre
Lallemand Health Solutions
Glac Biotech
Creative Biolabs
Chr. Hansen
Wecare Probiotics
Inactivated Probiotics Segment by Type
Radiation Inactivation
Ultrasound Inactivation
Heat Inactivation
Others
Inactivated Probiotics Segment by Application
Food and Beverages
Medicine and Health Products
Inactivated Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inactivated Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Probiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Inactivated Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiation Inactivation
- Ultrasound Inactivation
- Heat Inactivation
- Others
Applications
- Food and Beverages
- Medicine and Health Products
Companies covered
- IFF
- Huanyi
- Scitop
- GenMont Biotech
- Harbin Qiutianhong Health Technology Group
- Probioway
- Lesaffre
- Lallemand Health Solutions
- Glac Biotech
- Creative Biolabs
- Chr. Hansen
- Wecare Probiotics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Inactivated Probiotics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Inactivated Probiotics Sales Estimates and Forecasts (2021-2032)
- 1.3 Inactivated Probiotics Market by Type
- 1.3.1 Radiation Inactivation
- 1.3.2 Ultrasound Inactivation
- 1.3.3 Heat Inactivation
- 1.3.4 Others
- 1.4 Global Inactivated Probiotics Market Size by Type
- 1.4.1 Global Inactivated Probiotics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Inactivated Probiotics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Inactivated Probiotics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Inactivated Probiotics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Inactivated Probiotics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Inactivated Probiotics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Inactivated Probiotics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Inactivated Probiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Inactivated Probiotics Industry Trends
- 2.2 Inactivated Probiotics Industry Drivers
- 2.3 Inactivated Probiotics Industry Opportunities and Challenges
- 2.4 Inactivated Probiotics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Inactivated Probiotics Revenue (2021-2026)
- 3.2 Global Top Players by Inactivated Probiotics Sales (2021-2026)
- 3.3 Global Top Players by Inactivated Probiotics Price (2021-2026)
- 3.4 Global Inactivated Probiotics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Inactivated Probiotics Major Company Production Sites & Headquarters
- 3.6 Global Inactivated Probiotics Company, Product Type & Application
- 3.7 Global Inactivated Probiotics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Inactivated Probiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Inactivated Probiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Inactivated Probiotics Tier 1, Tier 2, and Tier 3
4 Inactivated Probiotics Regional Status and Outlook
- 4.1 Global Inactivated Probiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Inactivated Probiotics Historic Market Size by Region
- 4.2.1 Global Inactivated Probiotics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Inactivated Probiotics Sales in Value by Region (2021-2026)
- 4.2.3 Global Inactivated Probiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Inactivated Probiotics Forecasted Market Size by Region
- 4.3.1 Global Inactivated Probiotics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Inactivated Probiotics Sales in Value by Region (2027-2032)
- 4.3.3 Global Inactivated Probiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inactivated Probiotics by Application
- 5.1 Inactivated Probiotics Market by Application
- 5.1.1 Food and Beverages
- 5.1.2 Medicine and Health Products
- 5.2 Global Inactivated Probiotics Market Size by Application
- 5.2.1 Global Inactivated Probiotics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Inactivated Probiotics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Inactivated Probiotics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Inactivated Probiotics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Inactivated Probiotics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Inactivated Probiotics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Inactivated Probiotics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Inactivated Probiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 IFF
- 6.1.1 IFF Company Information
- 6.1.2 IFF Business Overview
- 6.1.3 IFF Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 IFF Inactivated Probiotics Product Portfolio
- 6.1.5 IFF Recent Developments
- 6.2 Huanyi
- 6.2.1 Huanyi Company Information
- 6.2.2 Huanyi Business Overview
- 6.2.3 Huanyi Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Huanyi Inactivated Probiotics Product Portfolio
- 6.2.5 Huanyi Recent Developments
- 6.3 Scitop
- 6.3.1 Scitop Company Information
- 6.3.2 Scitop Business Overview
- 6.3.3 Scitop Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Scitop Inactivated Probiotics Product Portfolio
- 6.3.5 Scitop Recent Developments
- 6.4 GenMont Biotech
- 6.4.1 GenMont Biotech Company Information
- 6.4.2 GenMont Biotech Business Overview
- 6.4.3 GenMont Biotech Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 GenMont Biotech Inactivated Probiotics Product Portfolio
- 6.4.5 GenMont Biotech Recent Developments
- 6.5 Harbin Qiutianhong Health Technology Group
- 6.5.1 Harbin Qiutianhong Health Technology Group Company Information
- 6.5.2 Harbin Qiutianhong Health Technology Group Business Overview
- 6.5.3 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Product Portfolio
- 6.5.5 Harbin Qiutianhong Health Technology Group Recent Developments
- 6.6 Probioway
- 6.6.1 Probioway Company Information
- 6.6.2 Probioway Business Overview
- 6.6.3 Probioway Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Probioway Inactivated Probiotics Product Portfolio
- 6.6.5 Probioway Recent Developments
- 6.7 Lesaffre
- 6.7.1 Lesaffre Company Information
- 6.7.2 Lesaffre Business Overview
- 6.7.3 Lesaffre Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Lesaffre Inactivated Probiotics Product Portfolio
- 6.7.5 Lesaffre Recent Developments
- 6.8 Lallemand Health Solutions
- 6.8.1 Lallemand Health Solutions Company Information
- 6.8.2 Lallemand Health Solutions Business Overview
- 6.8.3 Lallemand Health Solutions Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Lallemand Health Solutions Inactivated Probiotics Product Portfolio
- 6.8.5 Lallemand Health Solutions Recent Developments
- 6.9 Glac Biotech
- 6.9.1 Glac Biotech Company Information
- 6.9.2 Glac Biotech Business Overview
- 6.9.3 Glac Biotech Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Glac Biotech Inactivated Probiotics Product Portfolio
- 6.9.5 Glac Biotech Recent Developments
- 6.10 Creative Biolabs
- 6.10.1 Creative Biolabs Company Information
- 6.10.2 Creative Biolabs Business Overview
- 6.10.3 Creative Biolabs Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Creative Biolabs Inactivated Probiotics Product Portfolio
- 6.10.5 Creative Biolabs Recent Developments
- 6.11 Chr. Hansen
- 6.11.1 Chr. Hansen Company Information
- 6.11.2 Chr. Hansen Business Overview
- 6.11.3 Chr. Hansen Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Chr. Hansen Inactivated Probiotics Product Portfolio
- 6.11.5 Chr. Hansen Recent Developments
- 6.12 Wecare Probiotics
- 6.12.1 Wecare Probiotics Company Information
- 6.12.2 Wecare Probiotics Business Overview
- 6.12.3 Wecare Probiotics Inactivated Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Wecare Probiotics Inactivated Probiotics Product Portfolio
- 6.12.5 Wecare Probiotics Recent Developments
7 North America by Country
- 7.1 North America Inactivated Probiotics Sales by Country
- 7.1.1 North America Inactivated Probiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Inactivated Probiotics Sales by Country (2021-2026)
- 7.1.3 North America Inactivated Probiotics Sales Forecast by Country (2027-2032)
- 7.2 North America Inactivated Probiotics Market Size by Country
- 7.2.1 North America Inactivated Probiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Inactivated Probiotics Market Size by Country (2021-2026)
- 7.2.3 North America Inactivated Probiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Inactivated Probiotics Sales by Country
- 8.1.1 Europe Inactivated Probiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Inactivated Probiotics Sales by Country (2021-2026)
- 8.1.3 Europe Inactivated Probiotics Sales Forecast by Country (2027-2032)
- 8.2 Europe Inactivated Probiotics Market Size by Country
- 8.2.1 Europe Inactivated Probiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Inactivated Probiotics Market Size by Country (2021-2026)
- 8.2.3 Europe Inactivated Probiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Inactivated Probiotics Sales by Country
- 9.1.1 Asia-Pacific Inactivated Probiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Inactivated Probiotics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Inactivated Probiotics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Inactivated Probiotics Market Size by Country
- 9.2.1 Asia-Pacific Inactivated Probiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Inactivated Probiotics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Inactivated Probiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Inactivated Probiotics Sales by Country
- 10.1.1 South America Inactivated Probiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Inactivated Probiotics Sales by Country (2021-2026)
- 10.1.3 South America Inactivated Probiotics Sales Forecast by Country (2027-2032)
- 10.2 South America Inactivated Probiotics Market Size by Country
- 10.2.1 South America Inactivated Probiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Inactivated Probiotics Market Size by Country (2021-2026)
- 10.2.3 South America Inactivated Probiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Inactivated Probiotics Sales by Country
- 11.1.1 Middle East and Africa Inactivated Probiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Inactivated Probiotics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Inactivated Probiotics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Inactivated Probiotics Market Size by Country
- 11.2.1 Middle East and Africa Inactivated Probiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Inactivated Probiotics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Inactivated Probiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Inactivated Probiotics Value Chain Analysis
- 12.1.1 Inactivated Probiotics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Inactivated Probiotics Production Mode & Process
- 12.2 Inactivated Probiotics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Inactivated Probiotics Distributors
- 12.2.3 Inactivated Probiotics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst